 we report a solid financial performance for the second quarter of 2019 with net income of $48.1 million or $0.55 per diluted share and adjusted earnings per diluted share of $0.61 per diluted share for the second quarter of 2019, excluding transaction-related expenses of $5.2 million and an income tax effect of adjustments to income of $0.4 million based on a tax rate of 17.2%.    
 we added 118 beds in the second quarter, including 72 new beds in existing facilities and 46 beds resulting from the acquisition of Bradford Recovery Center, a specialty treatment facility located in Millerton, Pennsylvania.    
 we also closed a 44-bed expansion at Sierra Tucson in late May and are seeing some progress on that as well.    
 we also retooled about 40 beds in the second quarter in the U.K. and we expect to bring those back online in the second half of the year.    
 we expect to see some impact from the retooling in the second half of the year as we wind-down those facilities.    
 we do expect to see some impact in the third quarter as we wind-down those facilities as